Lord, Abbett & Co. Llc

Source: SEC Form 13F · as of Mar 2026

Lord, Abbett & Co. Llc holds 48 biotech & pharma companies tracked by BioSniper, totaling $3.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$3.6M

CompanySharesValue
LLYELI LILLY & Co421,643$388K
JNJJOHNSON & JOHNSON1,482,192$362K
GILDGILEAD SCIENCES, INC.2,000,343$279K
PMPhilip Morris International Inc1,664,028$275K
GHGuardant Health Inc.1,899,113$175K
UTHRUNITED THERAPEUTICS Corp250,276$148K
TERNTerns Pharmaceuticals, Inc.2,812,938$148K
MDGLMADRIGAL PHARMACEUTICALS, INC.242,726$127K
NVSNovartis AG830,286$127K
COGTCogent Biosciences, Inc.3,181,270$122K
ARGXARGENX SE152,083$111K
ABVXAbivax SA854,920$95K
IQVIQVIA Holdings Inc.537,725$92K
UNHUnitedHealth Group Incorporated Common Stock (DE)302,119$82K
BBIOBridgeBio Pharma, Inc.1,023,341$76K
VRTXVERTEX PHARMACEUTICALS INC / MA166,509$74K
ABBVAbbVie Inc.339,863$74K
TEVATeva Pharmaceutical Industries Limited2,412,336$73K
INSMINSMED Inc397,261$65K
MCKMcKesson Corporation71,345$62K
TARSTarsus Pharmaceuticals, Inc.842,313$59K
MIRMMirum Pharmaceuticals, Inc.617,064$57K
ABTABBOTT LABORATORIES534,503$55K
IDXXIDEXX LABORATORIES INC /DE88,247$50K
ADPTAdaptive Biotechnologies Corp3,536,103$49K
PTCTPTC THERAPEUTICS, INC.617,121$42K
RYTMRHYTHM PHARMACEUTICALS, INC.348,953$30K
NKTRNEKTAR THERAPEUTICS405,080$29K
DNTHDianthus Therapeutics, Inc. /DE/299,210$25K
CGONCG Oncology, Inc.340,197$23K
GMEDGlobus Medical Inc.262,897$23K
PAHCPHIBRO ANIMAL HEALTH CORP397,714$22K
NUVLNuvalent, Inc.199,878$20K
ARWRARROWHEAD PHARMACEUTICALS, INC.312,824$20K
CORCencora Inc.56,994$18K
PTGXProtagonist Therapeutics, Inc163,459$17K
TECHBIO-TECHNE Corp291,115$15K
RVMDREVOLUTION MEDICINES, INC.134,233$13K
AZNASTRAZENECA PLC57,671$11K
RGENREPLIGEN CORP88,367$10K
PRAXPraxis Precision Medicines, Inc.29,619$10K
MLYSMineralys Therapeutics, Inc.300,913$8K
ORICOric Pharmaceuticals, Inc.542,598$7K
NAMSNEWAMSTERDAM PHARMA CO N.V.195,355$6K
TWSTTwist Bioscience Corp99,630$5K
IMCRImmunocore Holdings plc100,784$3K
FBRXForte Biosciences, Inc.114,635$3K
NEOGNEOGEN CORP284,020$3K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Lord, Abbett & Co. Llc — Biotech 13F Holdings & Portfolio | BioSniper